Covered recipient · General Payments record
LEENA SHAHLA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$13,164.39
- Reported across 134 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $2,730.00 | 1 |
| Travel and Lodging | $2,346.84 | 3 |
| Food and Beverage | $979.19 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CHIESI USA, INC. | $5,464.37 | 9 |
| Corcept Therapeutics | $468.19 | 5 |
| Novo Nordisk AS | $89.23 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.02 | 1 |
| Insulet Corporation | $16.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $18.02 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086136969 | CMS |
| Chiesi USA, Inc. | $112.55 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151820554 | CMS |
| Chiesi USA, Inc. | $220.02 | 10/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151820558 | CMS |
| Chiesi USA, Inc. | $498.95 | 10/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151820563 | CMS |
| Chiesi USA, Inc. | $108.56 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151820567 | CMS |
| Chiesi USA, Inc. | $49.99 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151820572 | CMS |
| Chiesi USA, Inc. | $51.99 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151820577 | CMS |
| Chiesi USA, Inc. | $64.44 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151820581 | CMS |
| Chiesi USA, Inc. | $1,627.87 | 12/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151820586 | CMS |
| Chiesi USA, Inc. | $2,730.00 | 12/19/2024 | Honoraria | Undisputed | 01/23/2026 | 1151820590 | CMS |
| Corcept Therapeutics | $112.53 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117757077 | CMS |
| Corcept Therapeutics | $90.50 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117757075 | CMS |
| Corcept Therapeutics | $124.61 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117757099 | CMS |
| Corcept Therapeutics | $16.67 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117757145 | CMS |
| Corcept Therapeutics | $123.88 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117757153 | CMS |
| Insulet Corporation | $16.22 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116795731 | CMS |
| Novo Nordisk Inc | $89.23 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097280608 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.